{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:42:14Z","timestamp":1792716134806,"version":"4.5.0"},"reference-count":27,"publisher":"Society of Nuclear Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.2967\/jnumed.120.249300","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T23:00:23Z","timestamp":1612566023000},"page":"1468-1474","source":"Crossref","is-referenced-by-count":28,"title":["Utility of <sup>211<\/sup>At-Trastuzumab for the Treatment of Metastatic Gastric Cancer in the Liver: Evaluation of a Preclinical \u03b1-Radioimmunotherapy Approach in a Clinically Relevant Mouse Model"],"prefix":"10.2967","volume":"62","author":[{"given":"Huizi Keiko","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukie","family":"Morokoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kodaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamon","family":"Kusumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Minegishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Nagatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumitaka","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"2022032307250585000_62.10.1468.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"2022032307250585000_62.10.1468.2","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.7150\/jca.30821","article-title":"Liver metastases in newly diagnosed gastric cancer: a population-based study from SEER","volume":"10","author":"Sun","year":"2019","journal-title":"J Cancer."},{"key":"2022032307250585000_62.10.1468.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61121-X"},{"key":"2022032307250585000_62.10.1468.4","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.3748\/wjg.v18.i19.2402","article-title":"Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis","volume":"18","author":"Dang","year":"2012","journal-title":"World J Gastroenterol."},{"key":"2022032307250585000_62.10.1468.5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12094-016-1523-z","article-title":"Impact of HER2 expression on outcome in gastric cancer patients with liver metastasis","volume":"19","author":"Jiang","year":"2017","journal-title":"Clin Transl Oncol."},{"key":"2022032307250585000_62.10.1468.6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.10.4285"},{"key":"2022032307250585000_62.10.1468.7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.21037\/tgh.2019.08.03","article-title":"Surgical management of metastatic gastric cancer: moving beyond the guidelines","volume":"4","author":"Guner","year":"2019","journal-title":"Transl Gastroenterol Hepatol."},{"key":"2022032307250585000_62.10.1468.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.205146"},{"key":"2022032307250585000_62.10.1468.9","doi-asserted-by":"publisher","DOI":"10.2174\/1874471011104030177"},{"key":"2022032307250585000_62.10.1468.10","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1111\/cas.13636","article-title":"Alpha-particle therapy for synovial sarcoma in the mouse using an astatine-211-labeled antibody against frizzled homolog 10","volume":"109","author":"Li","year":"2018","journal-title":"Cancer Sci."},{"key":"2022032307250585000_62.10.1468.11","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbrc.2018.10.157","article-title":"Targeted cancer cell ablation in mice by an alpha-particle-emitting astatine-211-labeled antibody against major histocompatibility complex class I chain-related protein A and B","volume":"506","author":"Li","year":"2018","journal-title":"Biochem Biophys Res Commun."},{"key":"2022032307250585000_62.10.1468.12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ijrobp.2007.06.023","article-title":"Therapeutic efficacy of astatine-211-labeled trastuzumab on radioresistant SKOV-3 tumors in nude mice","volume":"69","author":"Palm","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2022032307250585000_62.10.1468.13","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/cas.13282","article-title":"Locoregional therapy with alpha-emitting trastuzumab against peritoneal metastasis of human epidermal growth factor receptor 2-positive gastric cancer in mice","volume":"108","author":"Li","year":"2017","journal-title":"Cancer Sci."},{"key":"2022032307250585000_62.10.1468.14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.nucmedbio.2017.09.003","article-title":"Astatine-211 labeled anti-HER2 5F7 single domain antibody fragment conjugates: radiolabeling and preliminary evaluation","volume":"56","author":"Choi","year":"2018","journal-title":"Nucl Med Biol."},{"key":"2022032307250585000_62.10.1468.15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.apradiso.2014.09.012","article-title":"Production of 211At by a vertical beam irradiation method","volume":"94","author":"Nagatsu","year":"2014","journal-title":"Appl Radiat Isot."},{"key":"2022032307250585000_62.10.1468.16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.nimb.2005.01.079","article-title":"Tin accumulation in spermatozoa of the rats exposed to tributyltin chloride by synchrotron radiation x-ray fluorescence (SR-XRF) analysis with microprobe","volume":"231","author":"Homma-Takeda","year":"2005","journal-title":"Nucl Instrum Methods Phys Res B."},{"key":"2022032307250585000_62.10.1468.17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.tranon.2019.04.008","article-title":"Preclinical evaluation of the acute radiotoxicity of the alpha-emitting molecular-targeted therapeutic agent 211At-MABG for the treatment of malignant pheochromocytoma in normal mice","volume":"12","author":"Sudo","year":"2019","journal-title":"Transl Oncol."},{"key":"2022032307250585000_62.10.1468.18","unstructured":"Eckerman KF Endo A. MIRD: Radionuclide Data and Decay Schemes. 2nd ed. Society of Nuclear Medicine and Molecular Imaging; 2008:616, 624."},{"key":"2022032307250585000_62.10.1468.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.058651"},{"key":"2022032307250585000_62.10.1468.20","doi-asserted-by":"crossref","first-page":"e0178472","DOI":"10.1371\/journal.pone.0178472","article-title":"Validating alpha-particle emission from 211At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors","volume":"12","author":"Kodaira","year":"2017","journal-title":"PLoS One."},{"key":"2022032307250585000_62.10.1468.21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.216853"},{"key":"2022032307250585000_62.10.1468.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.radmeas.2005.02.013"},{"key":"2022032307250585000_62.10.1468.23","first-page":"2367","article-title":"Indication for hepatic resection in the treatment of liver metastasis from gastric cancer","volume":"30","author":"Makino","year":"2010","journal-title":"Anticancer Res."},{"key":"2022032307250585000_62.10.1468.24","doi-asserted-by":"publisher","DOI":"10.3109\/02656730903555696"},{"key":"2022032307250585000_62.10.1468.25","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3389\/fonc.2019.01353","article-title":"Surgery strategies for gastric cancer with liver metastasis","volume":"9","author":"Luo","year":"2019","journal-title":"Front Oncol."},{"key":"2022032307250585000_62.10.1468.26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/18744710113069990018","article-title":"Targeted alpha therapy with 227Th-trastuzumab of intraperitoneal ovarian cancer in nude mice","volume":"6","author":"Heyerdahl","year":"2013","journal-title":"Curr Radiopharm."},{"key":"2022032307250585000_62.10.1468.27","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1002\/cam4.2379","article-title":"Evaluation of novel highly specific antibodies to cancer testis antigen Centrin-1 for radioimmunoimaging and radioimmunotherapy of pancreatic cancer","volume":"8","author":"Jiao","year":"2019","journal-title":"Cancer Med."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.120.249300","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T14:28:38Z","timestamp":1648045718000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.120.249300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,1]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.2967\/jnumed.120.249300"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.120.249300","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,5]]}}}